Galen Medical Group

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Ulcerative colitis2 trials
• Crohn's disease1 trial
• Gastroparesis1 trial

Phase

• Phase 22 trials
• Phase 32 trials

Status

• Completed3 trials
• Active, not recruiting1 trial

Lead sponsor

• Eli Lilly and Company2 trials
• CinDome Pharma, Inc.1 trial
• Janssen Research & Development, LLC1 trial

Running trials

• Active, not recruiting

  A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT05242471· Phase 2· Janssen Research & Development, LLC· Source

Closed trials

• Completed

  A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis.

  NCT06899217· Phase 2· CinDome Pharma, Inc.· Source

• Completed

  A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT03524092· Phase 3· Eli Lilly and Company· Source

• Completed

  An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

  NCT03518086· Phase 3· Eli Lilly and Company· Source